--2025/Q1-- / 11.812M--
--2024/Q4-- / 7.579M--
Nov 4, 20242024/Q36.507M / 8.015M--
Aug 6, 20242024/Q27.323M / 10.015M--
May 7, 20242024/Q19.954M / 11.005M--
MicroStrategy
MSTR
NVIDIA
NVDA
Adobe
ADBE
Salesforce
CRM
Apple
AAPL
US Stock MarketDetailed Quotes
ABCL AbCellera Biologics
- 2.850
- +0.140+5.17%
Close Dec 20 16:00 ET
- 2.800
- -0.050-1.75%
Post 20:01 ET
841.79MMarket Cap-4.67P/E (TTM)
2.880High2.682Low2.08MVolume2.700Open2.710Pre Close5.90MTurnover1.09%Turnover RatioLossP/E (Static)295.37MShares6.05552wk High0.78P/B542.59MFloat Cap2.33552wk Low--Dividend TTM190.38MShs Float71.910Historical High--Div YieldTTM7.31%Amplitude2.335Historical Low2.830Avg Price1Lot Size
AbCellera Biologics Key Stats
AbCellera Biologics Q3 2024 Earnings Date
Currency：USDNov 4, 2024
| Estimate (YoY) | Actual (YoY) | Vs Estimate (% Chg) | |
| Revenue | 8.01M | 6.51M | -1.51M |
| Miss Est. | +21.45% | -1.39% | -18.81% |
| EPS | -0.13 | -0.17 | -0.04 |
| Miss Est. | -30.03% | -70.00% | -30.87% |
Analyst Rating
Nov 30, 2024
AbCellera Biologics Earnings Estimates
Revenue
EPS
EBIT
Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: USD
Actual
Estimate
Unlock Free Earnings Estimates
Open Account
AbCellera Biologics Earnings Reports
Read more
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Analysis
Price Target
No Data